Advanced search
Publication Cover
Leukemia & Lymphoma Volume 14, 1994 - Issue 3-4
Submit an article Journal homepage
26
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Determination of IL6, IL1, and IL4 in the Plasma of Patients with Multiple Myeloma

T. L. Kiss Ontario Cancer Institute, Institute of Medical Science, University of Toronto, Toronto, Canada
,
J. H. Lipton Ontario Cancer Institute, Institute of Medical Science, University of Toronto, Toronto, Canada
,
D. E. Bergsagel Ontario Cancer Institute, Institute of Medical Science, University of Toronto, Toronto, Canada
,
J. M. Meharchand Ontario Cancer Institute, Institute of Medical Science, University of Toronto, Toronto, Canada
,
N. Jamal Ontario Cancer Institute, Institute of Medical Science, University of Toronto, Toronto, Canada
,
M. D. Minden Ontario Cancer Institute, Institute of Medical Science, University of Toronto, Toronto, Canada
&
H. A. Messner Ontario Cancer Institute, Institute of Medical Science, University of Toronto, Toronto, Canada
 show all
Pages 335-340 | Received 27 May 1992, Published online: 01 Jul 2009

References

  • Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Tanabe O., Tanaka H., Kuramoto A., Kishimoto T. Autocrine generation and requirement of BSF-2/IL 6 for human multiple myelomas. Nature 1988; 332: 83–85
  • Shimizu S., Yoshioka R., Hirose Y., Sugai S., Tachibana J., Konda S. Establishment of two Interleukin 6 (B cell stimulatory factor/Interferon beta2)-dependent human bone-marrow derived myeloma cellines. J. Exp. Med. 1989; 169: 339–344
  • Kishimoto T. The biology of Interleukin 6. Blood 1989; 74: 1–10
  • Asaoku H., Kawano M., Iwato K., Tanabe O., Tanaka H., Hirano T., Kishimoto T., Kuramoto A. Decrease in BSF2/IL 6 response in advanced cases of multiple myeloma. Blood 1988; 72: 429–432
  • Klein B., Zhang X. G., Jourdan M., Content J., Houssiau F., Aarden L., Piechaczyk M., Bataille R. Paracrine rather than autocrine regulation of myeloma cell growth and differentiation by Interleukin 6. Blood 1989; 73: 517–526
  • Zhang X. G., Klein B., Bataille R. Interleukin 6 is a potent myeloma cell growth factor in patients with aggressive multiple myeloma. Blood 1989; 74: 11–13
  • Kawano M., Tanaka H., Ishikawa H., Nobuyoshi M., Iwato K., Asaoku H., Tanabe O., Kuramoto A. Interleukin 1 accelerates autocrine growth of myeloma cells through Interleukin 6 in human myeloma. Blood 1989; 73: 2145–2148
  • Hitzler J. K., Martinez-Valdez H., Bergsagel D. B., Minden M. D., Messner H. A. Role of Interleukin 6 in the proliferation of human multiple myeloma cell lines OCI-Myl to 7 established from patients with advanced stage of the disease. Blood 1991; 78: 1996–2004
  • Bataille R., Jourdan M., Zhang X. G., Klein B. Serum levels of Interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J. Clin. Invest. 1989; 84: 2008–2011
  • Solary E., Guiguet M., Zeller V., Casasnovas R. O., Caillot D., Chavanet P., Guy H., Mack G. Radioimmunoassay for the measurement of serum IL6 and its correlation with tumour cell mass parameters in multiple myeloma. Am. J. Hematol. 1992; 39: 163–171
  • Bell J. B. G., Montes A., Gooding R., Riches P., Cunningham D., Millar B. C. Comparison of Interleukin 6 levels in the bone marrow of multiple myeloma patients with disease severity and clonogenicity in vitro. Leukemia 1991; 5: 958–961
  • Aarden L. A., De Groot E. R., Schaap O. L., Lansdorp P. M. Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 1987; 17: 1411–1416
  • Onozaki K., Akiyama Y., Okano A., Hirano T., Kishimoto T., Hashimoto T., Yoshizawa K., Taniyama T. Synergistic regulatory effects of Interleukin 6 and Interleukin 1 on the growth and differentiation of human and mouse myeloid leukemic cell lines. Cancer Res. 1989; 49: 3602–3607
  • Almerigogna F., Giudizi M. G., Biagiotti R., Alessi A., Defrance T., Banchereau J., Ricci M., Romagnani S. Analysis of the B-cell growth-promoting activity of human IL-4, the co-stimulatory assay with anti-immunoglobulin antibodies. Comparison with the B-cell growth-promoting activity of other lymphokines. Immunology 1989; 67: 244–250
  • Lansdorp P. M., Aarden L. A., Calafat J., Zeijlemaker W. P. A growth factor dependent B cell hybridoma. Current Topics Microbiol. Immunol. 1986; 132: 105–113
  • Yamasaki K., Solberg L. A., Jamal N., Lockwood G., Tritchler D., Curtis J. E., Minden M. D., Mann K. G., Messner H. A. Hemopoietic colony growth-promoting activities in the plasma of bone marrow transplant recipients. J. Clin. Invest. 1988; 82: 255–261
  • Yee C., Sutcliffe S., Minden M. D. Interleukin 6 in the plasma of lymphoma patients. Exp. Hematol. 1990; 18: 648, abstract
  • Zhang X. G., Bataille R., Jourdan M., Saeland S., Banchereau J., Mannoni P., Klein B. Granulocyte-macrophage colony stimulating factor synergizes with Interleukin 6 on supporting the proliferation of human myeloma cells. Blood 1990; 76: 2599–2605

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.